tiprankstipranks
Trending News
More News >
Rentokil Initial (RTO)
NYSE:RTO

Rentokil Initial (RTO) AI Stock Analysis

Compare
97 Followers

Top Page

RTO

Rentokil Initial

(NYSE:RTO)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
$34.00
▲(3.79% Upside)
Rentokil Initial's overall stock score reflects strong financial performance and effective cash flow management, which are offset by technical indicators showing mixed signals and a high valuation. The company's strategic focus on revenue growth and market expansion supports its competitive positioning, but attention to rising debt levels and valuation concerns is necessary.
Positive Factors
Scale & Global Market Position
Rentokil's presence across 70+ countries provides durable scale advantages: broad commercial contracts, local regulatory know-how, and cross-border service standardization. Scale lowers unit costs, supports national account relationships, and creates higher barriers to entry for smaller competitors over months to years.
Recurring Revenue & Cash Generation
A subscription-based model for pest and hygiene services drives recurring revenue and predictable cash inflows. Robust operating cash flow and positive free cash flow conversion support reinvestment, working capital management and steady funding of capex or dividends, strengthening long-term financial flexibility.
Profitability and Margin Sustainability
Consistent revenue growth combined with healthy gross and net margins indicates effective pricing power and service mix. Sustained margins enable reinvestment in technology and field operations, preserving competitive advantage and return on equity across multi-quarter horizons despite industry cyclicality.
Negative Factors
Rising Debt Levels
An increasing debt load reduces financial flexibility and raises interest expense sensitivity if rates rise. Elevated leverage can constrain M&A optionality, capital allocation and buffer against downturns, making balance sheet management a structural risk over the next several quarters if deleveraging is not prioritized.
Inconsistent Free Cash Flow Growth
While operating cash flow is robust, uneven free cash flow growth signals variability in capex, working capital or one-off items. Persistent FCF volatility can limit reliable funding for dividends, buybacks or strategic investments and complicates long-term planning and investor confidence over multiple quarters.
Earnings Volatility (EPS Decline)
A substantial decline in EPS growth points to margin pressure, cost or pricing challenges, or non-operational impacts. Continued EPS volatility undermines retained earnings accumulation and can limit capital deployed to growth initiatives, making earnings recovery a medium-term operational priority.

Rentokil Initial (RTO) vs. SPDR S&P 500 ETF (SPY)

Rentokil Initial Business Overview & Revenue Model

Company DescriptionRentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial and residential customers. The company also provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and laundering of workwear, uniforms, cleanroom uniforms, and protective equipment. Further, the company installs and services interior and exterior plant displays, flowers, replica foliage, Christmas decorations, and ambient scenting for commercial businesses; offers property care services consisting of damp proofing, property conservation, and woodworm and wood rot treatment; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist industrial cleaning and disinfection services, including the professional and discreet disinfection of areas that have been exposed to bio-hazardous situations, such as crime and trauma scenes, prison cells, void properties, emergency vehicles, and healthcare establishments. Additionally, it offers a range of healthcare waste management services comprising the collection, disposal, and recycling of hazardous and offensive waste produced by businesses and organizations associated with the provision of healthcare; and color-coded sharps disposal bins to deal with various types of waste. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.
How the Company Makes MoneyRentokil Initial generates revenue through multiple streams, primarily from its pest control and hygiene service contracts. The company charges clients on a subscription basis for ongoing pest management services, which includes regular inspections, treatments, and preventative measures. Additionally, Rentokil Initial earns income from one-off services such as pest eradication and hygiene product sales. Strategic partnerships with businesses in various industries, such as food production and healthcare, enhance its service offerings and expand its customer base. Furthermore, the company's focus on innovation, including the development of smart pest control technologies, positions it to capture additional market share and drive revenue growth.

Rentokil Initial Key Performance Indicators (KPIs)

Any
Any
Revenue at Constant Rates by Geography
Revenue at Constant Rates by Geography
Analyzes revenue across different regions while adjusting for currency fluctuations, highlighting stable growth areas and potential vulnerabilities in diverse markets.
Chart InsightsRentokil Initial's revenue growth is primarily driven by North America, which has seen a significant increase since 2022, reflecting strategic expansion and strong market demand. Europe & LATAM and UK & Sub-Saharan Africa also show steady growth, indicating successful regional strategies. However, the absence of recent data for Europe and UK & Rest of World suggests potential restructuring or strategic shifts. The consistent growth in the Pacific region further supports a diversified revenue base, positioning Rentokil well for future resilience against regional economic fluctuations.
Data provided by:The Fly

Rentokil Initial Earnings Call Summary

Earnings Call Date:Mar 06, 2025
(Q4-2024)
|
% Change Since: |
Next Earnings Date:Mar 05, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong international growth and improvements in customer and colleague retention. However, it was overshadowed by challenges in North America, including lower-than-expected revenue growth, profit declines, and integration complexities. The company is implementing strategic changes to address these issues, but the overall sentiment reflects the significant challenges that remain.
Q4-2024 Updates
Positive Updates
International Revenue Growth
International businesses outside of North America delivered strong revenue growth of 8.2%, with organic revenue contributing 4.7%. Pest Control organic growth was particularly strong at 5.3%.
Customer and Colleague Retention
Colleague retention increased by 2.4%, reducing recruitment needs by around 1,000 people. Customer satisfaction improved with a one-point increase in Net Promoter Score and customer retention rose by 50 basis points.
Satellite Branch Expansion
Opened 10 satellite branches in Q4, with a plan to exceed 500 locations including satellites. The satellite branches are part of a strategy to enhance local presence and operational efficiency.
Workwear Business Performance
French Workwear business delivered revenue growth of 7.1%, all organic, with adjusted operating profit growing by 8.6% and margins at 17.7%.
International Business Growth
International revenue grew by 8.2% to GBP 2.2 billion, with 4.7% organic growth led by Pest Control and Workwear. The Europe and LatAm region saw a 5% increase, with adjusted operating profit also up by 5.7%.
Negative Updates
North America Underperformance
North American revenue grew by only 1.3%, with organic growth at 1.5%. Adjusted operating profit declined by 7% due to below-plan revenue growth and higher in-year investments.
Profit Decline and Margin Reduction
Adjusted operating profit was down 7.1% to GBP 860 million, with a corresponding margin reduction of 130 basis points.
Cost and Investment Inefficiencies
A portion of investments in 2024 did not drive optimal effectiveness, leading to suboptimal sales and marketing returns. These will be redirected in 2025.
Integration Challenges
The integration of Terminix is complex and has led to periods of disruption. The program is expected to be complete by the end of 2026, with significant cost savings anticipated post-integration.
Weak Q1 Start and Lead Generation Issues
Q1 2025 is off to a slow start due to weak lead flow, adverse weather, and the leap year effect. Lead generation and sales conversion are areas needing significant improvement.
Company Guidance
During the call, Rentokil Initial provided guidance on its performance and strategy for 2025. The company reported a revenue of GBP 5.6 billion in 2024, marking a 3.9% increase, with organic growth at 2.8%. The North American business underperformed with only 1.3% growth, while International saw an 8.2% increase. Customer retention improved by 60 basis points to 80.1%, and colleague retention increased by 4.2%. The company plans to continue its integration of Terminix, aiming to achieve operating profit margins above 20% by 2027. For 2025, Rentokil aims to enhance lead generation, improve sales conversion, and expand its branch network to over 500 locations, including new satellite branches. The company's capital allocation strategy prioritizes organic investment, bolt-on acquisitions, and a progressive dividend policy, with a target net debt-to-EBITDA ratio of 2 to 2.5x. Rentokil expects to meet market expectations for 2025 despite a slow start in Q1.

Rentokil Initial Financial Statement Overview

Summary
Rentokil Initial demonstrates strong financial performance with consistent revenue growth and solid profitability. The company maintains effective cash flow management, although increasing debt levels require attention. Continued strategic investments are crucial for sustaining long-term growth.
Income Statement
85
Very Positive
Rentokil Initial has demonstrated steady revenue growth, with a significant increase from 2020 to 2024. The gross profit margin and net profit margin indicate healthy profitability, although there was a slight decline in EBIT and EBITDA margins between 2023 and 2024. The company's ability to maintain a high revenue growth rate and strong margins highlights its competitive positioning in the corporate services industry.
Balance Sheet
78
Positive
The balance sheet reflects a strong equity base with a moderate debt-to-equity ratio, indicating prudent financial leverage. The equity ratio is stable, but there is a noticeable increase in total debt over the years. Return on equity is healthy, driven by consistent net income growth, though the rising debt level poses a potential risk if not managed carefully.
Cash Flow
82
Very Positive
Operating cash flow remains robust, supporting the company's free cash flow generation. The free cash flow to net income and operating cash flow to net income ratios are favorable, showcasing effective cash conversion. However, the free cash flow growth rate has been inconsistent, suggesting fluctuations in capital expenditures and cash management strategies.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.09B5.44B5.38B3.71B2.95B2.79B
Gross Profit796.00M726.00M4.45B977.00M714.80M653.00M
EBITDA1.07B990.00M1.16B748.00M580.00M517.00M
Net Income299.00M307.00M381.00M232.00M263.00M186.00M
Balance Sheet
Total Assets14.23B10.55B11.13B11.92B4.32B5.58B
Cash, Cash Equivalents and Short-Term Investments1.69B927.00M1.55B2.17B670.00M2.12B
Total Debt6.04B4.14B4.73B5.47B1.97B3.14B
Total Liabilities8.97B6.33B7.04B7.82B3.06B4.45B
Stockholders Equity5.27B4.23B4.09B4.10B1.26B1.13B
Cash Flow
Free Cash Flow645.00M507.00M526.00M414.00M407.20M382.60M
Operating Cash Flow840.00M678.00M737.00M604.00M567.10M535.10M
Investing Cash Flow-398.00M-373.00M-416.00M-1.20B-441.00M-497.00M
Financing Cash Flow-251.00M-752.00M-361.00M1.32B-417.10M229.00M

Rentokil Initial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price32.76
Price Trends
50DMA
29.85
Positive
100DMA
28.16
Positive
200DMA
25.92
Positive
Market Momentum
MACD
0.69
Positive
RSI
55.76
Neutral
STOCH
36.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RTO, the sentiment is Positive. The current price of 32.76 is above the 20-day moving average (MA) of 31.80, above the 50-day MA of 29.85, and above the 200-day MA of 25.92, indicating a bullish trend. The MACD of 0.69 indicates Positive momentum. The RSI at 55.76 is Neutral, neither overbought nor oversold. The STOCH value of 36.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RTO.

Rentokil Initial Risk Analysis

Rentokil Initial disclosed 27 risk factors in its most recent earnings report. Rentokil Initial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Rentokil Initial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$3.73B28.446.50%0.71%0.20%2.72%
69
Neutral
$2.77B17.789.10%2.20%4.62%102.72%
66
Neutral
$15.50B47.675.86%2.20%1.56%-32.50%
66
Neutral
$2.14B26.737.44%59.19%-35.47%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
$383.91M81.890.90%71.28%-89.20%
59
Neutral
$1.26B317.243.13%-3.40%-51.58%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RTO
Rentokil Initial
31.88
7.84
32.61%
ABM
ABM Industries
46.37
-5.42
-10.46%
ACTG
Acacia Research
4.07
-0.23
-5.35%
CBZ
CBIZ
40.59
-45.15
-52.66%
UNF
UniFirst
208.02
-12.65
-5.73%
BV
BrightView Holdings
13.80
-2.30
-14.29%

Rentokil Initial Corporate Events

Rentokil Initial Discloses Independent Franchise Partners’ Stake Dip Below 5% Threshold
Jan 20, 2026

On 15 January 2026, Independent Franchise Partners LLP marginally reduced its stake in Rentokil Initial plc, taking its holding below the 5% notification threshold to 4.98% of the company’s voting rights, equivalent to 125,795,910 shares, all held via indirect voting rights and with no exposure through financial instruments. The move, formally notified to Rentokil on 16 January and disclosed in a Form 6‑K filed on 19 January, signals only a slight change in the shareholder register but is notable for crossing a key regulatory reporting threshold, offering investors updated visibility on the composition of Rentokil’s institutional investor base and any incremental shifts in governance influence among major shareholders.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

BlackRock Lifts Rentokil Initial Stake to 11% of Voting Rights
Jan 16, 2026

On 14 January 2026, asset manager BlackRock Inc. increased its stake in Rentokil Initial plc, crossing a major shareholding threshold as defined under UK disclosure rules. The position, notified to the company on 15 January 2026 and disclosed in a January 2026 Form 6-K, shows BlackRock now controls 11.0% of Rentokil’s voting rights in aggregate, up from 10.02%, through a combination of direct shareholdings and various financial instruments, including American Depositary Receipts, securities lending positions and derivatives such as CFDs and ELNs. The move underscores the continued interest of large institutional investors in Rentokil Initial and slightly strengthens BlackRock’s influence among the company’s shareholder base, a development monitored closely by governance-focused stakeholders.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Rentokil Initial Discloses Independent Franchise Partners Crossing 5% Shareholding Threshold
Jan 14, 2026

On 14 January 2026, Rentokil Initial plc reported a change in significant shareholding, disclosing that London-based asset manager Independent Franchise Partners LLP had increased its stake in the company. A regulatory filing showed that on 12 January 2026 the investor’s holding rose from 4.9081% to 5.01% of Rentokil Initial’s voting rights, equivalent to 126,470,698 shares, with no additional exposure through financial instruments. Crossing the 5% threshold underscores continuing institutional support for Rentokil Initial and slightly broadens the influence of this shareholder in corporate voting matters, a development that may be closely watched by other investors and governance observers.

The most recent analyst rating on (RTO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Swedbank Robur Fonder AB Adjusts Stake in Rentokil Initial
Dec 5, 2025

On December 3, 2025, Swedbank Robur Fonder AB crossed a voting rights threshold in Rentokil Initial plc, holding 3.020865% of the voting rights. This acquisition or disposal of voting rights was formally notified on December 4, 2025, indicating a significant stake in the company, potentially impacting its shareholder dynamics and market perception.

The most recent analyst rating on (RTO) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Rentokil Initial Announces Change in Major Shareholder Holdings
Dec 5, 2025

On December 5, 2025, Rentokil Initial announced a change in major holdings, with GIC Private Limited crossing a threshold in its voting rights. This change reflects a slight decrease in GIC’s total voting rights from 5.241261% to 4.958379%, impacting the company’s shareholder composition and potentially influencing future corporate decisions.

The most recent analyst rating on (RTO) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Rentokil Initial Announces Change in Major Holdings
Nov 26, 2025

On November 26, 2025, Rentokil Initial plc announced a change in major holdings due to an acquisition or disposal of voting rights by Independent Franchise Partners, LLP. The notification revealed that on November 22, 2025, the voting rights held by Independent Franchise Partners decreased from 5% to 4.9081%, impacting the company’s shareholder structure.

The most recent analyst rating on (RTO) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the RTO Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025